Literature DB >> 19506128

Cerebral microbleeds: evidence of heightened risk associated with aspirin use.

Philip B Gorelick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19506128     DOI： 10.1001/archneurol.2009.85

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  7 in total

1.  ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly.

Authors:  Stephanie A Ward; Parnesh Raniga; Nicholas J Ferris; Robyn L Woods; Elsdon Storey; Michael J Bailey; Amy Brodtmann; Paul A Yates; Geoffrey A Donnan; Ruth E Trevaks; Rory Wolfe; Gary F Egan; John J McNeil
Journal:  Int J Stroke       Date:  2016-09-24       Impact factor: 5.266

Review 2.  Cerebral microhemorrhages: mechanisms, consequences, and prevention.

Authors:  Zoltan Ungvari; Stefano Tarantini; Angelia C Kirkpatrick; Anna Csiszar; Calin I Prodan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

3.  Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.

Authors:  José Rafael Romero; Sarah R Preis; Alexa Beiser; Charles DeCarli; Anand Viswanathan; Sergi Martinez-Ramirez; Carlos S Kase; Philip A Wolf; Sudha Seshadri
Journal:  Stroke       Date:  2014-04-08       Impact factor: 7.914

4.  Activation of elements in HERV-W family by caffeine and aspirin.

Authors:  Chunlan Liu; Yatang Chen; Shan Li; Honglian Yu; Jie Zeng; Xiuling Wang; Fan Zhu
Journal:  Virus Genes       Date:  2013-06-28       Impact factor: 2.332

5.  Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel.

Authors:  Lihong Ge; Xuehui Ouyang; Chao Ban; Haixia Yu; Qiong Wu; Hui Wu; Junguo Liang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

6.  Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women.

Authors:  Silke Kern; Ingmar Skoog; Svante Ostling; Jürgen Kern; Anne Börjesson-Hanson
Journal:  BMJ Open       Date:  2012-10-03       Impact factor: 2.692

7.  Iatrogeny of Alzheimer's disease: A view point.

Authors:  Manu Kothari; Lopa Mehta
Journal:  J Craniovertebr Junction Spine       Date:  2016 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.